RESUMO
This study examined changes in protein kinase C (PKC) isoforms in rodent fibroblasts (rat F111 and mouse NIH3T3), transformed by the polyoma virus middle T antigen (mT) and undergoing apoptosis in response to teniposide (VM26). The mT-transformed cells up-regulated PKC delta and down-regulated both PKC epsilon and PKC lambda expression, and were more sensitive to the drug than their non-transformed counterparts. The drug treatment further lowered the expression of PKC epsilon, triggered nuclear translocation of PKC delta and its site-specific proteolysis, consistent with the notion that changes in specific PKC isoforms play a role not only in the neoplastic transformation of fibroblasts, but also in their apoptotic response.
Assuntos
Transformação Celular Neoplásica , Isoenzimas/metabolismo , Proteína Quinase C/metabolismo , Teniposídeo/farmacologia , Células 3T3 , Animais , Antineoplásicos/farmacologia , Células Cultivadas , Expressão Gênica , Camundongos , Proteína Quinase C-delta , Proteína Quinase C-épsilon , RatosRESUMO
Five murine hepatocellular tumor cell lines (HepM-1-5) were isolated and grown in a synthetic medium added with hormones, growth factors and/or serum. The morphology of these lines ranged from a nearly homogeneous epithelial-like shape (HepM-2) to a stromal appearance (HepM-1). The remaining lines displayed a mixed morphology. For their proliferation all of the cell lines retained a clear dependence on the extracellular calcium level and hormonal and/or serum growth factors and, rather homogeneously, they did not express the albumin, alpha-fetoprotein (with the exception of HepM-2 cells), tyrosine aminotransferase, and ornithine transcarbamylase genes, whereas they all exhibited discrete levels of the ornithine aminotransferase mRNA. Only HepM-3 and HepM-5 lines expressed the procollagen type I gene.
Assuntos
Regulação Neoplásica da Expressão Gênica , Neoplasias Hepáticas Experimentais/fisiopatologia , RNA Mensageiro/genética , RNA Neoplásico/genética , Animais , Divisão Celular , Colágeno/genética , Técnicas In Vitro , Fígado/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos A , Ornitina Carbamoiltransferase/genética , Ornitina-Oxo-Ácido Transaminase/genética , Albumina Sérica/genética , Células Tumorais Cultivadas , Tirosina Transaminase/genética , alfa-Fetoproteínas/genéticaRESUMO
We have measured plasma aldosterone, plasma cortisol, and glucocorticoid and mineralocorticoid receptors in mononuclear leukocytes in 54 healthy aged subjects (60-97 years old) and in a group of 21 controls (21-50 years old). In addition all parameters and age were plotted for correlation. Plasma cortisol was significantly higher in the aged group (346 +/- 140 nmol/l) than in controls (260 +/- 120). Mean plasma aldosterone was not different in the two groups. Both Type I and II receptors in mononuclear leukocytes were lower in the aged group than in controls (Type I 198 +/- 96 and 272 +/- 97 receptors per cell; Type II 1738 +/- 801 and 3339 +/- 918 receptors per cell). A direct correlation was found between cortisol and age and between Type I and II receptors in aged subjects, and between cortisol and Type I receptors, and cortisol and Type II receptors in controls. When all subjects are plotted together, a direct correlation was observed between cortisol and age and between Type I and II receptors, and an inverse correlation between age and Type I and age and Type II receptors. We conclude that the parallel reduction of both Type I and II receptors with age is not due to prior cortisol increase, but the increase of plasma cortisol can be considered the result of age-dependent involution of these receptors.
Assuntos
Envelhecimento/sangue , Receptores de Glucocorticoides/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Aldosterona/sangue , Glucocorticoides/sangue , Humanos , Hidrocortisona/sangue , Pessoa de Meia-Idade , Mineralocorticoides/sangueRESUMO
The reverse transcriptase polymerase chain reaction (RT-PCR) was used to elucidate the expression of DNase I and its possible involvement in apoptotic genome degradation. Multiple PCR products were obtained from cDNAs of different rat and human cells. The subsequent cloning and sequence analysis of seven PCR products revealed that only one of them had the expected size (639 bp) and sequence identity to that of rat DNase I cDNA. The other six PCR products were characterized by either sequence insertions or deletions. To establish the origin of this molecular diversity, a genomic fragment of the rat DNase I gene was also isolated, subcloned, and sequenced. Sequence comparison of six cDNAs with the rat genomic DNA revealed that they, indeed, resulted from inclusion of introns or deletion of exons. Southern hybridizations of the RT-PCR products from a variety of mammalian cell lines, using the major DNase I cDNA fragment as a probe, showed that in some cells as many as 20 alternatively spliced transcripts could be detected. This complexity of splice variants was widespread, and cell-specific profiles differed by the relative concentration of each transcript. None of these spliced transcripts maintained an open reading frame containing an intact catalytic site, suggesting that they do not encode any functional proteins. These complicated alternative splicing events might, however, significantly contribute to the regulation of DNase I expression. There was no apparent increase of the major DNase I transcript after induction of apoptosis in the cell lines studied. Apoptotic cells appeared to have similar normal/alternative transcript ratios as the control cells, suggesting that DNase I may not be the endonuclease involved in DNA degradation during apoptosis.
Assuntos
Processamento Alternativo , Apoptose/fisiologia , Desoxirribonuclease I/biossíntese , Regulação Enzimológica da Expressão Gênica , Transcrição Gênica , Células 3T3 , Adenocarcinoma , Animais , Neoplasias da Mama , Linhagem Celular , Etoposídeo/toxicidade , Éxons , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Células Jurkat , Neoplasias Hepáticas Experimentais , Masculino , Camundongos , Células PC12 , Reação em Cadeia da Polimerase , Neoplasias da Próstata , Ratos , Células Tumorais Cultivadas , Regulação para CimaRESUMO
In this paper, we show that there is a two-step process of DNA fragmentation in apoptosis; DNA is first cleaved to large fragments of 50-300 kb that are subsequently cleaved to smaller oligonucleosomes in some, but not all cells. Significantly, only the first stage is considered essential for cell death since some cells, for example human MCF7 breast carcinoma cells and human NT2 neuronal cells, do not show this behavior but still display normal nuclear morphological apoptotic changes. In cells that usually produce small fragments blocking the second (internucleosomal) stage of DNA fragmentation prevents neither nuclear condensation nor apoptosis. We are beginning to understand why the extent of DNA fragmentation during apoptosis varies enormously and why it appears to be a function of the cell type not the inducer. Presumably, this reflects the content of not only endonuclease activit(ies) but also on the ability of the cells to activate caspases, particularly caspase-3, and other proteases that may be involved in endonuclease activation. Since NT2 cells activate caspase-3, but do not correctly process DFF45, other factors must also impinge on the inevitability of that process.
Assuntos
Apoptose/fisiologia , Caspases/metabolismo , DNA/metabolismo , Neurônios/metabolismo , Proteínas/metabolismo , Adenocarcinoma , Proteínas Reguladoras de Apoptose , Neoplasias da Mama , Caspase 3 , Linhagem Celular , Meios de Cultura Livres de Soro , Inibidores de Cisteína Proteinase/farmacologia , Fragmentação do DNA , DNA de Neoplasias/metabolismo , Eletroforese em Gel de Campo Pulsado , Feminino , Humanos , Cinética , Oligopeptídeos/farmacologia , Células Tumorais CultivadasRESUMO
Rat DNaseYb and its human homolog DHP2 are members of a new family of DNaseI-like endonucleases. They contain all the conserved amino acid residues to engage a DNaseI-like catalytic activity and the same molecular mechanisms of DNA hydrolysis. The sequence similarity can be extended to other families of nucleases, such as FEN-1, DNA polymerases, RNaseH and exonuclease III, involved in the ion-dependent hydrolysis of nucleic acids. Their unique features include the NLS signals that place them in the nuclei and a high content of positively charged amino acid residues that results in their high affinity for the substrate. Their properties are consistent with a role in the early stage DNA degradation during apoptosis. The caspase-DFF45/CIDE-CPAN pathway is most likely involved in the second stage of internucleosomal DNA degradation. However, cells express constitutively multiple transcripts encoding DNA degrading enzymes and related molecules, hence they have the molecular diversity to engage the self-destructive pathway appropriate to a given trigger.
Assuntos
Apoptose , Desoxirribonuclease I/genética , Desoxirribonuclease I/metabolismo , Família Multigênica , Sequência de Aminoácidos , Animais , Fragmentação do DNA , Desoxirribonuclease I/química , Humanos , Dados de Sequência Molecular , Ratos , Alinhamento de Sequência , Homologia de Sequência de AminoácidosRESUMO
The feasibility of using antigenically disguised skin xenotransplants to cover extensive burns for a suitable time lag without administering immunosuppressive drugs was tested experimentally. Pieces of human skin that had been preincubated for 3 h at 37 degrees C with either mouse anti-human beta 2-microglobulin monoclonal antibody (beta 2m-McAb) or PBS (controls) were grafted onto the backs of immunologically competent Swiss mice, and the time required for their rejection or substitution by normal autogenous skin was determined. Thus, it was found that the beta 2m-McAb-pretreated xenografts had a significantly longer mean survival time than the control grafts. An even longer skin xenograft MST was obtained when beta 2m-McAb was repeatedly injected, at weekly intervals, just beneath the transplants. Parallel immunohistochemical studies showed that the beta 2m-McAb entered the grafts and was bound to its targets both in epidermis and dermis. Moreover, a small amount of beta 2m-McAb administered at the outset significantly hindered the reactive proliferation of primed mouse spleen cells cultured in the presence of human epidermal cells. Finally, neither toxic effects nor a weakening of immune competence were elicited by repeated intraperitoneal injections of beta 2m-McAb. Therefore, it seems expedient to propose the use of beta 2m-McAb to delay the rejection of skin xenografts as this antibody harmlessly prevents, wholly or in part, the activation of the recipients' lymphocytes. This would positively aid any patient urgently needing xenograft cover of extensive burns.
Assuntos
Anticorpos Monoclonais/administração & dosagem , Sobrevivência de Enxerto , Transplante de Pele , Transplante Heterólogo , Microglobulina beta-2/imunologia , Animais , Anticorpos Monoclonais/toxicidade , Feminino , Humanos , Teste de Cultura Mista de Linfócitos , Camundongos , Camundongos Endogâmicos , Pele/citologia , Pele/imunologia , Imunologia de TransplantesRESUMO
The cells in nearly pure (96-98%) primary cultures of hepatocytes from neonatal rat liver in high (1.0 mM)-Ca2+, serum-free, synthetic HiWo5Ba2000 medium initiated DNA synthesis and entered mitosis between 11 and 30 h after the addition of 10 ng/ml EGF. During the 10-h prereplicative period, the cultured hepatocytes, like regenerating rat liver cells, generated two large cyclic AMP transients, one peaking between 30 min and 2 h and the other around 6 h. Hepatocytes stimulated by the same concentration of EGF in low (0.02 mM)-Ca2+ medium increased cyclic AMP synthesis as much as the EGF-treated hepatocytes in high-Ca2+ medium, but they released the additional cyclic AMP into the medium and could not generate prereplicative internal cyclic AMP surges, initiate DNA replication, or enter mitosis. These results suggest that one of the ways external Ca2+ controls prereplicative development of hepatocytes is to restrain the release of cyclic AMP and thus enable the cell to accumulate enough internal cyclic AMP to stimulate events required to initiate DNA replication.
Assuntos
Cálcio/metabolismo , AMP Cíclico/metabolismo , Fator de Crescimento Epidérmico/farmacologia , Espaço Extracelular/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Animais , Animais Recém-Nascidos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Meios de Cultura/metabolismo , Fígado/citologia , Ratos , Ratos WistarRESUMO
As revealed by a novelin utero-in vitro hepatocarcinogenesis model, a single exposure to dimethylnitrosamine (DMN) elicited in postnatal (and fetal) primary rat hepatocytes (i) immunocytochemically detectable, widespread increases in their complement of thealpha, mu and especiallypi classes of cytosolic glutathione S-transferases (GST's); and (ii) changed patterns (with respect to controls) of the phenobarbital (PB)-evoked increases in steady state levels ofc-jun andc-myc mRNA's. These results indicate that DMN causes both transient cytotoxic effects and a broad, permanent initiation in fetal proliferating hepatocytes.
RESUMO
Four tumor promoters, i.e. PB, TPA, NAF, and DDT, added singly to a calcium-deprived synthetic medium, elicited early and late mitogenic effects and concurrent surges of nuclear poly(ADP-ribose) polymerase (pADPRP) activity in primary neonatal rat hepatocytes mutagenized with an intra-uterine dose of DMN. These actions were fully abated by the pADPRP inhibitor 3-MBA. Conversely, EGF only acted as a full mitogen when medium's calcium was at physiological levels, and its effects could not be blocked by 3-MBA. The same tumor promoters, but not EGF, also evoked a swift and lingering amplification of pADPRP transcripts in DMN-initiated hepatocytes kept in low-calcium medium. Hence, a coordinated modulation of both pADPRP transcripts and activity by xenobiotics is likely to be involved in the clonal expansion of early preneoplastic hepatocytes.
Assuntos
Núcleo Celular/enzimologia , Replicação do DNA/efeitos dos fármacos , Dimetilnitrosamina/toxicidade , Neoplasias Hepáticas/fisiopatologia , Fígado/efeitos dos fármacos , Poli(ADP-Ribose) Polimerases/genética , Poli(ADP-Ribose) Polimerases/metabolismo , Lesões Pré-Cancerosas/fisiopatologia , Transcrição Gênica/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Benzamidas/farmacologia , Cálcio/farmacologia , Ciclo Celular/efeitos dos fármacos , Células Cultivadas , Fator de Crescimento Epidérmico/farmacologia , Feminino , Cinética , Fígado/enzimologia , Fígado/patologia , Fígado/fisiologia , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/patologia , Troca Materno-Fetal , Mutagênese , Fenobarbital/farmacologia , Lesões Pré-Cancerosas/induzido quimicamente , Lesões Pré-Cancerosas/patologia , Gravidez , Ratos , Ratos Endogâmicos , Fluoreto de Sódio/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Timidina/metabolismoRESUMO
As revealed by a novel in utero-in vitro hepatocarcinogenesis model, a single exposure to dimethylnitrosamine (DMN) elicited in postnatal (and fetal) primary rat hepatocytes (i) immunocytochemically detectable, widespread increases in their complement of the alpha, mu and especially pi classes of cytosolic glutathione S-transferases (GSTs); and (ii) changed patterns (with respect to controls) of the phenobarbital (PB)-evoked increases in steady state levels of c-jun and c-myc mRNA's. These results indicate that DMN causes both transient cytotoxic effects and a broad, permanent initiation in fetal proliferating hepatocytes.
Assuntos
Dimetilnitrosamina/toxicidade , Fígado/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Biotecnologia , Células Cultivadas , Feminino , Genes jun/efeitos dos fármacos , Genes myc/efeitos dos fármacos , Glutationa Transferase/metabolismo , Fígado/citologia , Fígado/metabolismo , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/enzimologia , Neoplasias Hepáticas Experimentais/genética , Troca Materno-Fetal , Fenobarbital/farmacologia , Gravidez , RatosRESUMO
A rat gene, designated DNaseY, encoding a 36 kDa endonuclease was identified and cloned. Sequence analysis of the cDNA showed it to be the rat homologue of human DNAS1L3. The DNaseY gene product had 42% identity to DNaseI, including conserved critical active site residues, the essential disulfide bridge, the calcium binding domain, and a signal peptide, as well as 2 of the 3 signature boxes. Significantly, DNaseY had 2 nuclear localization signals and was more basic (pI 9.5) than DNaseI (pI 4.8). The DNaseY gene contained a number of exons similar to that of DNaseI, separated by much larger introns, resulting in a gene of >17 kb compared to <4 kb gene of DNaseI. The 36 kDa DNaseY gene product was catalytically inactive but was converted to an active 33 kDa endonuclease following processing of the hydrophobic signal peptide. Antibody generated against peptides representing the predicted amino acid sequence of DNaseY cross-reacted with a 33 kDa nuclear protein which possessed endonucleolytic activity. The enzyme was active over a broad pH range (optimum pH 7-8), was Ca2+/Mg2+-dependent, was inhibited by Zn2+, and was capable of both single- and double-stranded DNA cleavage, producing DNA fragments with 3'-OH ends. Furthermore, the DNaseY gene was expressed constitutively in all cells and tissues tested, but it was not transcriptionally up-regulated in apoptotic cells. All these features were consistent with a role in the early stages of apoptotic DNA fragmentation.